Myo1c is overexpressed in gastric cancer [84]; a recent study found that patients with overexpression of miRNA 137 showed a downregulation of Myosin 1 c and higher survival rates, Myosin 1 c has three isoforms (A, B, and C), Isoform A was the target of miR137, interestingly the same isoform A is overexpressed in prostate cancer, which might make it a potential molecular marker for prostate cancer detection [85]. Here, MYO1C is linked to prostate carcinoma.